Publication | Closed Access
Effects of adjunct treatment with intravenous immunoglobulins on the course of severe COVID-19: results from a retrospective cohort study
25
Citations
17
References
2020
Year
Clinically relevant benefits through adjunct IVIG treatment in COVID-19 need to be confirmed in a randomized, controlled trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1